Specialists for Chronic myeloid leukemia

60 physicians and care centers identified from ClinicalTrials.gov trial PIs, PubMed publications, and the NPPES NPI registry.

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Brian J Druker
Rare Disease Specialist
Providence Saint Joseph Medical Center/Disney Family Cancer Center
Burbank, California
QC-verified 1
Hagop Kantarjian, MD, MD
Rare Disease / Clinical Research
M.D. Anderson Cancer Center
HOUSTON, TX
PI×8
Brenda Sandmaier
Rare Disease / Clinical Research
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
SEATTLE, WA
PI×18
Minocher Battiwalla, MD, MD
Rare Disease / Clinical Research
National Institutes of Health- NHLBI
NASHVILLE, TN
PI×2
David Maloney
Rare Disease / Clinical Research
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
PI×11
Corey Cutler, MD, MPH, F.N.P
Rare Disease / Clinical Research
Dana-Farber Cancer Institute
PARK CITY, UT
PI×3
Farhad Ravandi-Kashani, MD, M.D
Rare Disease / Clinical Research
M.D. Anderson Cancer Center
HOUSTON, TX
PI×11
Jorge Cortes, MD
Rare Disease / Clinical Research
UT MD Anderson Cancer Center
PI×23
Mary Horowitz, MD, MS, LCSW
Rare Disease / Clinical Research
Center for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin
CHICAGO, IL
PI×11
Elias Jabbour, MD, M.D
Rare Disease / Clinical Research
M.D. Anderson Cancer Center
HOUSTON, TX
PI×13
Jorge Cortes
Rare Disease / Clinical Research
M.D. Anderson Cancer Center
PI×7 8
Paolo Caimi, MD, M.D
Rare Disease / Clinical Research
Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center
CLEVELAND, OH
PI×5
Thomas G. Martin, MD
Rare Disease / Clinical Research
University of California, San Francisco
PI×4
Horst Olschewski, MD
Rare Disease / Clinical Research
Medical University of Graz
PI×9
Guillermo Garcia-Manero, M.D
Rare Disease / Clinical Research
M.D. Anderson Cancer Center
HOUSTON, TX
PI×10
Mikkael A Sekeres, MD
Rare Disease / Clinical Research
SWOG Cancer Research Network
MIAMI, FL
PI×1 3
Guillermo M Bravo, MD, MD
Rare Disease / Clinical Research
M.D. Anderson Cancer Center
CHANDLER, AZ
PI×1 1
Andrew Rezvani, MD
Rare Disease / Clinical Research
Stanford University
STANFORD, CA
PI×2
Anne Kuan, MD
Rare Disease / Clinical Research
Neovii Biotech
SAN ANTONIO, TX
PI×1
Claudio G. Brunstein, MD, PhD, M.D., PhD
Rare Disease / Clinical Research
Masonic Cancer Center, University of Minnesota
MINNEAPOLIS, MN
PI×6
Samuel Dychter, MD
Rare Disease / Clinical Research
Fate Therapeutics
PI×1
Margaret L. MacMillan, MD
Rare Disease / Clinical Research
Masonic Cancer Center, University of Minnesota
PI×4
Franck-Emmanuel NICOLINI, MD
Rare Disease / Clinical Research
Centre Leon Berard
PI×1
Raphaël Itzykson, MD
Rare Disease / Clinical Research
Saint-Louis Hospital, Paris, France
PI×1
Pierre Fenaux, MD, PHD
Rare Disease / Clinical Research
Saint-Louis Hospital, Paris, France
PI×1
Jürgen Wehmeyer, Dr.
Rare Disease / Clinical Research
Hämatologisch-onkologische Gemeinschaftspraxis
PI×1
François-Xavier MAHON, Pr
Rare Disease / Clinical Research
University Hospital Bordeaux, France
PI×1
ehsan mohajeri
Department of pharmaceutics, Faculty of pharmacy, Kerman University of medical sciences
QC-verified PI×1
Ellin Berman
Memorial Sloan Kettering Cancer Center
QC-verified PI×1
Dennis Kim
University Health Network, Toronto
QC-verified PI×2
Elisabetta Abruzzese
Ospedale S. Eugenio Roma
QC-verified PI×2
Deborah A. Thomas
M.D. Anderson Cancer Center
QC-verified PI×1
Aaron P. Rapoport, M.D
University of Maryland Greenebaum Cancer Center
BALTIMORE, MD
QC-verified PI×1
Ilana Monteleone
Novartis Pharmaceuticals
QC-verified PI×2
David E Avigan, M.D
Beth Israel Deaconess Medical Center
QC-verified PI×1
Carlo Gambacorti
Ospedale San Gerardo - Monza (MI)
QC-verified PI×1
Emilie CAYSSIALS
Poitiers University Hospital
QC-verified PI×1
Tiong Ong, MD
University of California Medical Center At Irvine-Orange Campus
ORANGE, CA
QC-verified PI×1
IL-yang Pharm
IL-YANG Pharmaceutical.Co.,Ltd.
QC-verified PI×2
Tom Christian Martinsen
St Olavs Hospital, Clinical of Internal Medicine
QC-verified PI×1
Zihai Li, M.D
UConn Health
COLUMBUS, OH
QC-verified PI×1
Satu Mustjoki
Helsinki University Central Hospital, helsinki, Finland
QC-verified PI×1
Carmen Fava
Dip. di Scienze Cliniche e Biologiche - Ospedale S. Luigi Gonzaga-Medicina Interna 2 - Orbassano
QC-verified PI×3
Catherine M. Verfaillie
Masonic Cancer Center, University of Minnesota
QC-verified PI×1
Safwat Mangoura
Pharmacology department, Faculty of Medicine, Assiut University
QC-verified PI×1
Carmen Escalante
M.D. Anderson Cancer Center
QC-verified PI×2
Henni Samir
Angers Teaching Hospital
QC-verified PI×1
Steegmann Juan Luis, Dr
PETHEMA Foundation
QC-verified PI×1
Helen Collins
Enliven Therapeutics
QC-verified PI×1
Susanne Saussele
Universitätsmedizin Mannheim, Universität Heidelberg
QC-verified PI×1
Koji Sasaki, M.D
M.D. Anderson Cancer Center
HOUSTON, TX
QC-verified PI×1
Osman Ilhan
Ankara University Medical Faculty Department of Hematology
QC-verified PI×1
Carol Cheung, RN, BSN
Queen Mary Hospital, Hong Kong
QC-verified PI×1
Heather Jim
H. Lee Moffitt Cancer Center and Research Institute
FARMINGTON HILLS, MI
QC-verified PI×1
Jan Cerny, M.D
University of Massachusetts, Worcester
WORCESTER, MA
QC-verified PI×1
Thomas Ernst
University Hospital Jena
QC-verified PI×1
Susanne Geiselhart
Heidelberg University
QC-verified PI×1
Sara Galimberti
University of Pisa - Dept. Clinical and Experimental Medicine
QC-verified PI×1
Frederic MILLOT
Poitiers University Hospital
QC-verified PI×1
Na Yun Kim
Il-Yang Pharm. Co., Ltd.
BROOKLYN, NY
QC-verified PI×1

More about Chronic myeloid leukemia

Disease overview →
Treatments →
Clinical trials →